Huntington National Bank’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3 | Hold |
1
| – | – | ﹤0.01% | 4002 |
|
|
2025
Q4 | $3 | Hold |
1
| – | – | ﹤0.01% | 3911 |
|
|
2025
Q3 | $3 | Hold |
1
| – | – | ﹤0.01% | 3942 |
|
|
2025
Q2 | $3 | Hold |
1
| – | – | ﹤0.01% | 3946 |
|
|
2025
Q1 | $3 | Hold |
1
| – | – | ﹤0.01% | 3954 |
|
|
2024
Q4 | $3 | Hold |
1
| – | – | ﹤0.01% | 3960 |
|
|
2024
Q3 | $3 | Hold |
1
| – | – | ﹤0.01% | 3951 |
|
|
2024
Q2 | $3 | Hold |
1
| – | – | ﹤0.01% | 3902 |
|
|
2024
Q1 | $3 | Hold |
1
| – | – | ﹤0.01% | 3775 |
|
|
2023
Q4 | $3 | Hold |
1
| – | – | ﹤0.01% | 3674 |
|
|
2023
Q3 | $3 | Hold |
1
| – | – | ﹤0.01% | 3651 |
|
|
2023
Q2 | $3 | Hold |
1
| – | – | ﹤0.01% | 3599 |
|
|
2023
Q1 | $3 | Hold |
1
| – | – | ﹤0.01% | 3471 |
|
|
2022
Q4 | $3 | Hold |
1
| – | – | ﹤0.01% | 3335 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2633 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2637 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2564 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2491 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2217 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2106 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 1996 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1973 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1918 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1932 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2026 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2039 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1944 |
|
|
2019
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 1975 |
|
|
2019
Q1 | – | Sell |
-1
| Closed | – | – | 1972 |
|
|
2018
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2023 |
|
|
2018
Q3 | $0 | Buy |
+1
| New | +$4 | ﹤0.01% | 2011 |
|
Huntington National Bank's KERX Position: Q1 2026 in Review
Huntington National Bank held its Keryx Biopharmaceuticals Inc (KERX) position steady in Q1 2026 at 1 share worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #4002.
Huntington National Bank first reported a position in KERX in Q3 2018 and has held it in 30 quarters since. 1 fund tracked by Wall St. Rank holds KERX as of Q1 2026.
- Huntington National Bank held 1 share of Keryx Biopharmaceuticals Inc worth $3 as of Q1 2026.
- Huntington National Bank left its Keryx Biopharmaceuticals Inc share count unchanged in Q1 2026.
- Keryx Biopharmaceuticals Inc made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #4002 holding.
- Huntington National Bank first reported a position in Keryx Biopharmaceuticals Inc in Q3 2018 and has held it in 30 quarters since.
- 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.